Observational studyRevista medica del Instituto Mexicano del Seguro Social2024
[Cardiotoxicity from anti-HER-2 therapies in patients with HER-2 positive breast cancer].
Natalia Camejo-Martínez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.